The latest dividend was paid out to all shareholders who bought their shares by 9 March 2023 (the "ex-dividend date"). Novartis AG ADR's most recent dividend payout was on 20 March 2023. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth. Novartis AG ADR's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. In Novartis AG ADR's case, that would currently equate to about $3.461 per share. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Novartis AG ADR shareholders could enjoy a 3.62% return on their shares, in the form of dividend payments. That has enabled analysts to estimate a "forward annual dividend yield" of 3.62% of the current stock value. Recently Novartis AG ADR has paid out, on average, around 54.46% of net profits as dividends. TTM: trailing 12 months Novartis AG ADR share dividends 54%ĭividend payout ratio: 54.46% of net profits The EBITDA is a measure of a Novartis AG ADR's overall financial performance and is widely used to measure a its profitability. Novartis AG ADR's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $18.6 billion. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies. The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Novartis AG ADR's future profitability. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value. Novartis AG ADR's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.7688. The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued. That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). In other words, Novartis AG ADR shares trade at around 30x recent earnings. ![]() Novartis AG ADR's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 30x. All international money transfer services.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |